Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate

Annals of the Rheumatic Diseases

Volumn 56, Issue 2, 1997, Pages 97-102

  Bologna, Christophe ^a   Picot, Marie Christinne ^a   Jorgensen, Christian ^a   Viu, Philippe ^a   Verdier, Regis ^a   Sany, Jacques ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0030890863     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.2.97     Document Type: Article

References (33)

1. Matteson EL, Hickey AR, Maguire L, Tilson HH, Urowitz MB. Occurrence of neoplasia in patients with rheumatoid arthritis in a DMARD registry. J Rheumatol 1991;18:809-14.
2. Symmons DPM. Neoplasms of the immune system in rheumatoid arthritis. Am J Med 1985;78(suppl 1A):22-8.
3. Prior P. Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 1985;78(suppl 1A):15-21.
4. Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985;78(suppl 1A):44-9.
5. Silman AJ, Petrie J, Hazleman B, Evans SJW. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine:a 20 year follow up study. Ann Rheum Dis 1988;47:988-92.
6. Colburn KK, Cao JD. Thymoma associated with rheumatoid arthritis in a patient taking methotrexate. J Rheumatol 1986;13:437-9.
7. Pointud P, Prudat M, Peron JM. Acute leukemia after low dose methotrexate therapy in a patient with rheumatoid arthritis. J Rheumatol 1993;20:1215-6.
8. Trenkwalder P, Eisenlohr H, Prechtel K, Lydtin H. Three cases of malignant neoplasm, pneumonitis, and pancytopenia during treatment with low-dose methotrexate. Clin Invest 1992;70:951-5.
9. Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C. Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 1991;18:1172-5.
10. Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991; 18:1741-3.
11. Cobeta-Garcia JC, Ruiz-Jimeno MT, Fontova-Garrofe R. Non-Hodgkin's lymphoma, rheumatoid arthritis and methotrexate. J Rheumatol 1993;20:200-1.
12. Le Goff P, Koreichi A, Saraux A, Baron D. Lymphome au cours du traitement de la polyarthrite rhumatoïde par le méthotrexate à faible dose: un nouveau cas. Rev Rhum Mal Osteoartic 1994;61:357-63.
13. Kamel OW, Van de Rijn M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA, et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occuring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N EnglJ Med 1993;328:1317-21.
14. Morris CR, Morris AJ. Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate. J Rheumatol 1993;20:2172-3.
15. Kingsmore SF, Hall BD, Allen NB, Rice JR, Caldwell DS. Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review. J Rheumatol 1992;19:1462-5.
16. Cardon T, Heuschling C, Delaporte E, Cotten H, Catteau B, Farre JM, et al. Pseudolymphome cutané au cours d'une polyarthrite rhumatoïdetraitée par méthotrexate. Rev Rhum Mal Osteoartic 1994;61:740.
17. Lioté F, Pertuiset E, Cochand-Priollet B, D'Agay MF, Dombret H, Numeric P, et al. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. J Rheumatol 1995;22:1174-8.
18. Zimmer-Galler I, Lie JT. Choroidal infiltrates as the initial manifestation of lymphoma in rheumatoid arthritis after treatment with low-dose methotrexate. Mayo Clin Proc 1994;69:258-61.
19. Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW. Methotrexate-associated lymphoma in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:325-9.
20. Taillan B, Garnier G, Ferrari E, Castanet J, Pesce, A, Fuzibet JG, et al. Lymphome malin au cours d'une polyarthrite rhumatoïde traitée par de faibles doses de méthotrexate. Rev Rhum Mal Osteoartic 1993;60:248-50.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Registre des tumeurs de l'Hérault. Le cancer dans l'Hérault. Association Registre des tumeurs de l'Hérault, Epidaure, Montpellier, France, 1989-1990 et 1991-1992.
23. Kerr LD, Troy K, Isola L. Temporal association between the use of methotrexate and development of leukemia in 2 patients with rheumatoid arthritis. J Rheumatol 1995; 22:2356-8.
24. Kchir MM, Aloui S, Ben Taarit C, Hajri R, Karoui M, Zouari R, et al. Lymphome malin non-hodgkinien et polyarthrite rhumatoïde. Sem Hop Paris 1992;68:1457-9.
25. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in Sicca syndrome. Ann Intern Med 1978;89:888-92.
26. Holm LE, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985;312:601-4.
27. Kamel OW, Van de Rijn M, Lebrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994;25:638- 43.
28. Castor CW, Bull FE. Review of United States data on neoplasms in rheumtoid arthritis. Am J Med 1985;78(suppl 1A):33-8.
29. Lindskov R, Wulf HC, Wantzin GL, Niebuhr E. Sister chromatid exchange in patients treated with methotrexate for psoriasis. J Invest Dermatol 1984;82:458-9.
30. Bailin PL, Tindall JP, Roenigk HH, Hogan MD. Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis. JAMA 1975; 232:359-62.
31. Rustin GJS, Rustin F, Dent J, Booth M, Salt S, Bagshawe KD. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors. N Engl J Med 1983;308:473-6.
32. McKendry RJR, Dale P. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol 1993;20:1850-6.
33. Moder KG, Tefferi A, Cohen MD, Menke DM, Luthra HS. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med 1995;99:276-81.